Seeing Is Believing
Currently out of the existing stock ratings of Matt O'brien, 610 are a BUY (83.68%), 113 are a HOLD (15.5%), 6 are a SELL (0.82%).
Analyst Matt O'brien works at PIPER SANDLER with a stock forecast success ratio of 61.71% fulfilled within 162.78 days on average.
Matt O'brien’s has documented 1,499 price targets and ratings displayed on 54 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FNA, Paragon 28 at 27-Mar-2024.
Analyst best performing recommendations are on RMED (RA MEDICAL SYSTEMS).
The best stock recommendation documented was for KRMD (REPRO MED SYSTEMS) at 1/25/2021. The price target of $4.5 was fulfilled within 1 day with a profit of $0.63 (12.28%) receiving and performance score of 122.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
388
$6.98 (1.83%)
355
1 years 4 months 26 days ago
2/5 (40%)
$14.49 (3.88%)
88
Hold
380
$-1.02 (-0.27%)
235
1 years 4 months 26 days ago
1/2 (50%)
$6.49 (1.74%)
36
Hold
380
$-1.02 (-0.27%)
350
1 years 4 months 27 days ago
24/41 (58.54%)
$2.18 (0.58%)
138
Buy
300
$-81.02 (-21.26%)
425
1 years 5 months 16 days ago
1/2 (50%)
$57.23 (23.57%)
20
Sell
235
$-146.02 (-38.32%)
275
1 years 8 months 13 days ago
6/8 (75%)
$-33.23 (-12.39%)
142
Which stock is Matt O'brien is most bullish on?
Which stock is Matt O'brien is most reserved on?
What Year was the first public recommendation made by Matt O'brien?